SEC Form 4 · accession 0001209191-15-009286
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
G Jan Van Heek
Director
Period of report
Feb 2, 2015
Accepted (ET)
Feb 4, 2015 · 1:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | — | Feb 2, 2015 | A | 7,500 | A | — | Feb 1, 2025 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1The exercise price shall be the closing price of of the Issuer's common stock on February 2, 2015.
- F2The shares shall vest in 4 equal quarterly installments from the effective date of Award Determination.